Wednesday, October 13, 2021

Cellibre Snags $11.5M For Cannabis Biotech Effort

San Diego-based Cellibre, which says it is developing ways to produce cannabinoids using pharmaceutical cell lines rather than traditional agriculture, has raised $11.5M in a Series A funding. The company said the funding was led by Merida Capital Holdings, and also included Scott Gordon, Flatiron Venture Partners, L2V, Entourage Effect Capital, and De

The story you have requested is only available to paid members of the socalTECH.com web site. Premium articles are restricted to paid members only. Please login in order to access this members-only content, or become a member.